Wells Fargo’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.07M | Buy |
|
|||||
|
2025
Q2 | $2.01M | Sell |
|
|||||
|
2025
Q1 | $1.77M | Sell |
|
|||||
|
2024
Q4 | $1.72M | Buy |
|
|||||
|
2024
Q3 | $1.56M | Buy |
|
|||||
|
2024
Q2 | $691K | Buy |
|
|||||
|
2024
Q1 | $508K | Buy |
|
|||||
|
2023
Q4 | $335K | Sell |
|
|||||
|
2023
Q3 | $2.31M | Sell |
|
|||||
|
2023
Q2 | $2.26M | Buy |
|
|||||
|
2023
Q1 | $1.4M | Buy |
|
|||||
|
2022
Q4 | $99.6K | Buy |
|
|||||
|
2022
Q3 | $59K | Sell |
|
|||||
|
2022
Q2 | $17K | Sell |
|
|||||
|
2022
Q1 | $58K | Sell |
|
|||||
|
2021
Q4 | $274K | Buy |
|
|||||
|
2021
Q3 | $11K | Buy |
|
|||||
|
2021
Q2 | $6K | Sell |
|
|||||
|
2021
Q1 | $11K | Sell |
|
|||||
|
2020
Q4 | $774K | Buy |
|
|||||
|
2020
Q3 | $196K | Sell |
|
|||||
|
2020
Q2 | $532K | Buy |
|
|||||
|
2020
Q1 | $130K | Buy |
|
|||||
|
2019
Q4 | $70K | Buy |
|
|||||
|
2019
Q3 | $9K | Buy |
|